Api5 as a Suppressor of E2F-Dependent Apoptosis
Author Information
Author(s): Morris Erick J, Michaud William A, Ji Jun-Yuan, Moon Nam-Sung, Rocco James W, Dyson Nicholas J
Primary Institution: Massachusetts General Hospital Cancer Center
Hypothesis
Api5 is a critical determinant of E2F1-induced apoptosis in vivo and in vitro.
Conclusion
Api5 suppresses E2F-dependent apoptosis, and its depletion is lethal to tumor cells.
Supporting Evidence
- Api5 is upregulated in tumor cells, particularly in metastatic cells.
- Depletion of Api5 is tumor cell lethal.
- The interaction between E2F and Api5 is conserved from flies to humans.
- Api5 expression does not generally block E2F-dependent transcription.
Takeaway
Api5 helps cells survive when they are supposed to die, which is important for cancer cells that have messed up their growth controls.
Methodology
The study used Drosophila as a model to identify genetic modifiers of E2F-dependent apoptosis through genetic screening and in vitro assays.
Limitations
The study primarily focuses on Drosophila, which may not fully represent human biology.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website